Drug intelligence / Profile preview

AB-Digest Kids

Development stage: Unknown
Lead developer: AB-BIOTICS
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

AB-Digest Kids is a pediatric probiotic formulation developed by AB-BIOTICS to support digestive health and manage functional gastrointestinal disorders (FGID) in children. The product consists of a proprietary blend of three probiotic strains: *Lactobacillus plantarum* KABP-022 (CECT 7484), *Lactobacillus plantarum* KABP-023 (CECT 7485), and *Pediococcus acidilactici* KABP-021 (CECT 7483). These strains are selected for their ability to survive the gastrointestinal environment, adhere to the intestinal mucosa, and produce metabolites that inhibit the growth of pathogenic bacteria while promoting a balanced gut microbiota. Clinical evidence suggests that this specific combination is effective in reducing the duration and severity of pediatric diarrhea and alleviating symptoms of functional abdominal pain in children.

Brand names: AB-Digest Kids

Beyond the preview

Go deeper on AB-Digest Kids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AB-Digest Kids.

Explore the full profile